Turn Therapeutics (TTRX) Share-based Compensation (2024 - 2026)
Turn Therapeutics (TTRX) recorded quarterly Share-based Compensation of $155830.0 in Q1 2026, down 39.22% quarter-over-quarter from $256375.0 in Q4 2025, and up 103.49% on a YoY basis from $76580.0 in Q1 2025.
Turn Therapeutics (TTRX) Share-based Compensation (2024 - 2026) Analysis & Trends
Turn Therapeutics' Share-based Compensation history runs 3 years deep, the most recent figure standing at $155830.0 for Q1 2026.
- In Q1 2026, Share-based Compensation rose 103.49% year-over-year to $155830.0; the TTM figure through Mar 2026 stood at $526598.0 (changed N/A YoY), while the FY2025 annual figure was $419245.0, up 18.82% from the prior year.
- Share-based Compensation was $155830.0 for Q1 2026 at Turn Therapeutics, down from $256375.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $256375.0 in Q4 2025 to a low of $37813.0 in Q4 2024.
- Historically, Share-based Compensation has averaged $131649.5 across 3 years, with a median of $116205.0 in 2025.
- The sharpest annual moves came in 2025 and 2026: Share-based Compensation soared 578.01% in 2025, then surged 103.49% in 2026.
- A 3-year view of Share-based Compensation shows it stood at $37813.0 in 2024, then jumped by 578.01% to $256375.0 in 2025, then sank by 39.22% to $155830.0 in 2026.
- The last three Share-based Compensation figures came in at $155830.0 (Q1 2026), $256375.0 (Q4 2025), and $76580.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26.47 Mn |
| 10 | Turn Therapeutics | 175.38 Mn | 175.38 Mn | - | 155,830.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 155,830.00 |
| Mar 31, 2026 | 155,830.00 |
| Dec 31, 2025 | 256,375.00 |
| Dec 31, 2025 | 256,375.00 |
| Mar 31, 2025 | 76,580.00 |
| Mar 31, 2025 | 76,580.00 |
| Dec 31, 2024 | 37,813.00 |
| Dec 31, 2024 | 37,813.00 |